Related Experiment Videos
Colorectal carcinoma as a genetic phenomenon
1Department of Clinical Pathomorphology, School of Medicine, Poznań.
Abstract:
Carcinogenesis in human large intestine is a result of multiple, heterogeneous and random genetic changes. Deletion of tumor suppressor genes and activation of oncogenes appear to be important molecular events. These compromise the loss of chromosomes 5, 17, 18 or functional inactivation of FAP, p53 and DCC genes. Activation of Ki-ras and c-myc oncogenes seems to be crucial for both cell immortalization and morphology modification. Identification of genes involved in this process enables both a screening and a new classification. Also it is an important step towards a gene therapy.
Insights
Genetic changes drive human large intestine cancer through tumor suppressor gene deletion and oncogene activation. Identifying these genes aids screening, classification, and gene therapy development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer arises from accumulated genetic alterations.
- Key events include tumor suppressor gene inactivation and oncogene activation.
Purpose of the Study:
- To elucidate the genetic underpinnings of human large intestine carcinogenesis.
- To identify critical genes involved in cancer development for improved diagnostics and therapeutics.
Main Methods:
- Analysis of genetic changes in colorectal cancer.
- Focus on chromosomal deletions and gene mutations.
Main Results:
- Loss of chromosomes 5, 17, and 18 is frequently observed.
- Functional inactivation of genes such as Familial Adenomatous Polyposis (FAP), p53, and Deleted in Colorectal Carcinoma (DCC) is implicated.
- Activation of Ki-ras and c-myc oncogenes is crucial for cell immortalization and morphological changes.
Conclusions:
- Genetic alterations, including specific gene deletions and activations, are central to colorectal carcinogenesis.
- Gene identification facilitates novel screening methods and cancer classification.
- Understanding these genetic events is a prerequisite for developing effective gene therapies.